Logical Assessment
Long/short equity, biotech, small-cap, micro-cap

As The Patent Cliff Approaches, Buy TrovaGene

Alarming Shifts in Healthcare

I'm not James Altucher, but I do believe in investing in companies that stand to benefit from "long-term demographic trends." These long-term demographic trends tend to be very transparent for the healthcare sector. The IMS Institute for Health recently released a report, Declining Medicine Use: For Better or Worse?, detailing their findings on the current state of healthcare. Salient aspects of the report are as follows:

    "Total spending on medicines on a real per capita basis declined by 3.5%." "Overall healthcare spending is growing more rapidly than spending on medicines and is expected to do so at least through 2017." "Nominal spending on pharmaceuticals reached $325.8 billion in 2012, a decline of 1.0% ...
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details